OCULAR THERAPEUTIX, INC Increase (Decrease) in Accrued Liabilities
OCULAR THERAPEUTIX, INC (OCUL) reported Increase (Decrease) in Accrued Liabilities of -$6.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-03
- OCULAR THERAPEUTIX, INC increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $1.47M, a 48.22% decline year-over-year.
- OCULAR THERAPEUTIX, INC increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$8.44M.
- OCULAR THERAPEUTIX, INC increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $2.18M, a 48.26% decline year-over-year.
- OCULAR THERAPEUTIX, INC increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $5.38M, a 4.05% decline year-over-year.
- OCULAR THERAPEUTIX, INC increase (decrease) in accrued liabilities for fiscal 2025 was $5.25M, a 44.26% increase from fiscal 2024.
- OCULAR THERAPEUTIX, INC increase (decrease) in accrued liabilities for fiscal 2024 was $3.64M, a 370.63% increase from fiscal 2023.
- OCULAR THERAPEUTIX, INC increase (decrease) in accrued liabilities for fiscal 2023 was $773.00K, a 52.98% decline from fiscal 2022.
- OCULAR THERAPEUTIX, INC increase (decrease) in accrued liabilities for fiscal 2022 was $1.64M, a 55.77% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$6.97M 10-Q · filed 2026-08-03 | -$4.79M derived: sum of 3 quarters · filed 2026-08-03 | $582.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$8.44M 10-Q · filed 2026-05-05 | -$6.26M derived: sum of 2 quarters · filed 2026-05-05 | -$889.00K derived: sum of 3 quarters · filed 2026-05-05 | $1.95M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | $7.55M derived: sum of 2 quarters · filed 2026-02-05 | $10.39M derived: sum of 3 quarters · filed 2026-08-03 | $5.25M 10-K · filed 2026-02-05 |
| 2025-09-30 | $5.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $8.22M derived: sum of 2 quarters · filed 2026-08-03 | $3.07M 10-Q · filed 2025-11-04 | $7.28M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $2.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$2.30M 10-Q · filed 2026-08-03 | $1.90M derived: sum of 3 quarters · filed 2026-08-03 | $7.50M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$5.14M 10-Q · filed 2026-05-05 | -$939.00K derived: sum of 2 quarters · filed 2026-05-05 | $4.66M derived: sum of 3 quarters · filed 2026-05-05 | $12.52M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | $9.81M derived: sum of 2 quarters · filed 2026-02-05 | $17.67M derived: sum of 3 quarters · filed 2026-02-05 | $3.64M 10-K · filed 2026-02-05 |
| 2024-09-30 | $5.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $13.46M derived: sum of 2 quarters · filed 2025-11-04 | -$568.00K 10-Q · filed 2025-11-04 | -$1.81M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-06-30 | $7.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$6.17M 10-Q · filed 2025-08-05 | -$7.42M derived: sum of 3 quarters · filed 2026-02-05 | -$4.82M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-03-31 | -$14.03M 10-Q · filed 2025-05-05 | -$15.28M derived: sum of 2 quarters · filed 2026-02-05 | -$12.68M derived: sum of 3 quarters · filed 2026-02-05 | -$10.63M derived: sum of 4 quarters · filed 2026-02-05 |
| 2023-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | $1.35M derived: sum of 2 quarters · filed 2026-02-05 | $3.40M derived: sum of 3 quarters · filed 2026-02-05 | $773.00K 10-K · filed 2026-02-05 |
| 2023-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $4.65M derived: sum of 2 quarters · filed 2024-11-14 | $2.02M 10-Q · filed 2024-11-14 | $3.96M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$578.00K 10-Q · filed 2024-08-07 | $1.36M derived: sum of 3 quarters · filed 2025-03-03 | $3.01M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$2.63M 10-Q · filed 2024-05-07 | -$691.00K derived: sum of 2 quarters · filed 2025-03-03 | $962.00K derived: sum of 3 quarters · filed 2025-03-03 | $2.06M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $3.59M derived: sum of 2 quarters · filed 2025-03-03 | $4.69M derived: sum of 3 quarters · filed 2025-03-03 | $1.64M 10-K · filed 2025-03-03 |
| 2022-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.75M derived: sum of 2 quarters · filed 2023-11-07 | -$293.00K 10-Q · filed 2023-11-07 | -$105.00K derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$1.95M 10-Q · filed 2023-08-07 | -$1.76M derived: sum of 3 quarters · filed 2024-03-11 | $843.00K derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | -$3.05M 10-Q · filed 2023-05-08 | -$2.86M derived: sum of 2 quarters · filed 2024-03-11 | -$259.00K derived: sum of 3 quarters · filed 2024-03-11 | $1.78M derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | $188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $2.79M derived: sum of 2 quarters · filed 2024-03-11 | $4.83M derived: sum of 3 quarters · filed 2024-03-11 | $3.72M 10-K · filed 2024-03-11 |
| 2021-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $4.64M derived: sum of 2 quarters · filed 2022-11-07 | $3.53M 10-Q · filed 2022-11-07 | $4.93M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $928.00K 10-Q · filed 2022-08-08 | $2.33M derived: sum of 3 quarters · filed 2023-03-06 | $5.11M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | -$1.11M 10-Q · filed 2022-05-09 | $289.00K derived: sum of 2 quarters · filed 2023-03-06 | $3.07M derived: sum of 3 quarters · filed 2023-03-06 | $3.82M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $4.18M derived: sum of 2 quarters · filed 2023-03-06 | $4.93M derived: sum of 3 quarters · filed 2023-03-06 | $2.31M 10-K · filed 2023-03-06 |
| 2020-09-30 | $2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $3.53M derived: sum of 2 quarters · filed 2021-11-08 | $911.00K 10-Q · filed 2021-11-08 | $2.08M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $751.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$1.87M 10-Q · filed 2021-08-09 | -$695.00K derived: sum of 3 quarters · filed 2022-02-28 | $717.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$2.62M 10-Q · filed 2021-05-05 | -$1.45M derived: sum of 2 quarters · filed 2022-02-28 | -$34.00K derived: sum of 3 quarters · filed 2022-02-28 | $988.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $2.58M derived: sum of 2 quarters · filed 2022-02-28 | $3.60M derived: sum of 3 quarters · filed 2022-02-28 | $1.71M 10-K · filed 2022-02-28 |
| 2019-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.43M derived: sum of 2 quarters · filed 2020-11-05 | $543.00K 10-Q · filed 2020-11-05 | $2.14M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$869.00K 10-Q · filed 2020-08-07 | $730.00K derived: sum of 3 quarters · filed 2020-08-07 | $1.58M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | -$1.89M 10-Q · filed 2020-05-08 | -$292.00K derived: sum of 2 quarters · filed 2020-05-08 | $558.00K derived: sum of 3 quarters · filed 2020-05-08 | $596.00K derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $2.45M derived: sum of 2 quarters · filed 2020-03-12 | $2.49M derived: sum of 3 quarters · filed 2020-03-12 | $1.71M 10-K · filed 2020-03-12 |
| 2018-09-30 | $850.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $888.00K derived: sum of 2 quarters · filed 2019-11-12 | $112.00K 10-Q · filed 2019-11-12 | -$269.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$738.00K 10-Q · filed 2019-08-07 | -$1.12M derived: sum of 3 quarters · filed 2020-03-12 | -$492.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | -$776.00K 10-Q · filed 2019-05-10 | -$1.16M derived: sum of 2 quarters · filed 2020-03-12 | -$530.00K derived: sum of 3 quarters · filed 2020-03-12 | $1.94M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | -$381.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $246.00K derived: sum of 2 quarters · filed 2020-03-12 | $2.71M derived: sum of 3 quarters · filed 2020-03-12 | $2.56M 10-K · filed 2020-03-12 |
| 2017-09-30 | $627.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $3.09M derived: sum of 2 quarters · filed 2018-11-07 | $2.94M 10-Q · filed 2018-11-07 | $4.47M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $2.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $2.31M 10-Q · filed 2018-08-07 | $3.84M derived: sum of 3 quarters · filed 2019-03-07 | $4.29M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | -$153.00K 10-Q · filed 2018-05-08 | $1.38M derived: sum of 2 quarters · filed 2019-03-07 | $1.82M derived: sum of 3 quarters · filed 2019-03-07 | $1.66M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $1.98M derived: sum of 2 quarters · filed 2019-03-07 | $1.81M derived: sum of 3 quarters · filed 2019-03-07 | $1.39M 10-K · filed 2019-03-07 |
| 2016-09-30 | $446.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $281.00K derived: sum of 2 quarters · filed 2017-11-07 | -$143.00K 10-Q · filed 2017-11-07 | -$458.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | -$165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$589.00K 10-Q · filed 2017-08-08 | -$904.00K derived: sum of 3 quarters · filed 2018-03-08 | $10.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | -$424.00K 10-Q · filed 2017-05-05 | -$739.00K derived: sum of 2 quarters · filed 2018-03-08 | $175.00K derived: sum of 3 quarters · filed 2018-03-08 | $599.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | -$315.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $599.00K derived: sum of 2 quarters · filed 2018-03-08 | $1.02M derived: sum of 3 quarters · filed 2018-03-08 | $219.00K 10-K · filed 2018-03-08 |
| 2015-09-30 | $914.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.34M derived: sum of 2 quarters · filed 2016-11-09 | $534.00K 10-Q · filed 2016-11-09 | $1.38M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | $424.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$380.00K 10-Q · filed 2016-08-09 | $470.00K derived: sum of 3 quarters · filed 2017-03-10 | $1.12M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-03-31 | -$804.00K 10-Q · filed 2016-05-10 | $46.00K derived: sum of 2 quarters · filed 2017-03-10 | $700.00K derived: sum of 3 quarters · filed 2017-03-10 | $1.34M derived: sum of 4 quarters · filed 2017-03-10 |
| 2014-12-31 | $850.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $1.50M derived: sum of 2 quarters · filed 2017-03-10 | $2.14M derived: sum of 3 quarters · filed 2017-03-10 | $1.95M 10-K · filed 2017-03-10 |
| 2014-09-30 | $654.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $1.29M derived: sum of 2 quarters · filed 2015-11-10 | $1.10M 10-Q · filed 2015-11-10 | $1.13M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $638.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $442.00K 10-Q · filed 2015-08-10 | $471.00K derived: sum of 3 quarters · filed 2016-03-10 | $740.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | -$196.00K 10-Q · filed 2015-05-15 | -$167.00K derived: sum of 2 quarters · filed 2016-03-10 | $102.00K derived: sum of 3 quarters · filed 2016-03-10 | |
| 2013-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $298.00K derived: sum of 2 quarters · filed 2016-03-10 | -$210.00K 10-K · filed 2016-03-10 | |
| 2013-09-30 | $269.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$239.00K 10-Q · filed 2014-11-12 | ||
| 2013-06-30 | -$508.00K 10-Q · filed 2014-08-29 | |||
| 2012-12-31 | $610.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |